NYT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
New York Times Co's Capital Expenditure for the three months ended in Sep. 2024 was $-7.06 Mil. Its Revenue for the three months ended in Sep. 2024 was $640.18 Mil.
Hence, New York Times Co's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.01.
The historical data trend for New York Times Co's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New York Times Co Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Capex-to-Revenue | Get a 7-Day Free Trial | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
New York Times Co Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Capex-to-Revenue | Get a 7-Day Free Trial | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
For the Publishing subindustry, New York Times Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Media - Diversified industry and Communication Services sector, New York Times Co's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where New York Times Co's Capex-to-Revenue falls into.
New York Times Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (-22.669) | / | 2426.152 | |
= | 0.01 |
New York Times Co's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as
Capex-to-Revenue | = | - Capital Expenditure | / | Revenue |
= | - (-7.061) | / | 640.178 | |
= | 0.01 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New York Times Co (NYSE:NYT) Capex-to-Revenue Explanation
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Thank you for viewing the detailed overview of New York Times Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Kopit Levien Meredith A. | officer: EVP & Chief Operating Officer | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
William Bardeen | officer: Chief Financial Officer | 620 EIGHTH AVENUE, NEW YORK NY 10018 |
R Anthony Benten | officer: SVP, Treasurer & Controller | C/O THE NEW YORK TIMES CO, 229 WEST 43RD ST, NEW YORK NY 10036 |
Diane Brayton | officer: EVP, GENERAL COUNSEL & SEC | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
David S. Perpich | director | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
Arthur G. Sulzberger | director, officer: Publisher, The New York Times | THE NEW YORK TIMES COMPANY, 620 8TH AVENUE, NEW YORK NY 10018 |
Roland A. Caputo | officer: Interim CFO and EVP | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
Manuel Bronstein | director | 970 PARK PLACE, SUITE 100, SAN MATEO CA 94403 |
Beth A. Brooke | director | C/O EHEALTH, INC., 2625 AUGUSTINE DRIVE, SECOND FLOOR, SANTA CLARA CA 95054 |
Jacqueline M Welch | officer: EVP and CHRO | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
Arthur S. Golden | director | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
Mark Thompson | director, officer: PRESIDENT & CEO | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
Arthur Jr Sulzberger | director, officer: Chairman and Publisher | THE NEW YORK TIMES COMPANY, 620 EIGHTH AVENUE, NEW YORK NY 10018 |
Robert E Denham | director | MUNGER, TOLLES & OLSON LLP, 355 S. GRAND AVENUE, 35TH FLOOR, LOS ANGELES CA 90071 |
Doreen A Toben | director | 140 WEST STREET, 29TH FLOOR, NEW YORK NY 10007 |
From GuruFocus
By Business Wire • 09-27-2024
By Business Wire • 06-27-2024
By GuruFocus Research • 05-09-2024
By GuruFocus News • 11-04-2024
By GuruFocus Research • 03-06-2024
By Business Wire • 02-16-2024
By Business Wire • 05-13-2024
By GuruFocus News • 11-05-2024
By GuruFocus Research • 04-01-2024
By GuruFocus Research • 05-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.